Structure activity relationship modelling of milk protein-derived peptides with dipeptidyl peptidase IV (DPP-IV) inhibitory activity

Alice B. Nongonierma,Richard J. FitzGerald

DOI: https://doi.org/10.1016/j.peptides.2016.03.005

IF: 3.867

2016-05-01

Peptides

Abstract:Quantitative structure activity type models were developed in an attempt to predict the key features of peptide sequences having dipeptidyl peptidase IV (DPP-IV) inhibitory activity. The models were then employed to help predict the potential of peptides, which are currently reported in the literature to be present in the intestinal tract of humans following milk/dairy product ingestion, to act as inhibitors of DPP-IV. Two models (z- and v-scale) for short (2-5 amino acid residues) bovine milk peptides, behaving as competitive inhibitors of DPP-IV, were developed. The z- and the v-scale models (p<0.05, R(2) of 0.829 and 0.815, respectively) were then applied to 56 milk protein-derived peptides previously reported in the literature to be found in the intestinal tract of humans which possessed a structural feature of DPP-IV inhibitory peptides (P at the N2 position). Ten of these peptides were synthetized and tested for their in vitro DPP-IV inhibitory properties. There was no agreement between the predicted and experimentally determined DPP-IV half maximal inhibitory concentrations (IC50) for the competitive peptide inhibitors. However, the ranking for DPP-IV inhibitory potency of the competitive peptide inhibitors was conserved. Furthermore, potent in vitro DPP-IV inhibitory activity was observed with two peptides, LPVPQ (IC50=43.8±8.8μM) and IPM (IC50=69.5±8.7μM). Peptides present within the gastrointestinal tract of human may have promise for the development of natural DPP-IV inhibitors for the management of serum glucose.

pharmacology & pharmacy,biochemistry & molecular biology,endocrinology & metabolism

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to predict the key features of milk - protein - derived peptides with dipeptidyl peptidase IV (DPP - IV) inhibitory activity through quantitative structure - activity relationship (QSAR) modeling. Specifically, the researchers developed two models (z - scale and v - scale models) for predicting the potential of short (2 - 5 amino acid residues) bovine milk peptides as DPP - IV competitive inhibitors. These models were then applied to 56 milk - protein - derived peptides known to exist in the human intestine to evaluate their potential as DPP - IV inhibitors. The main purpose of the study was to verify whether peptides released from the digestion process of milk proteins can inhibit DPP - IV, and thus may have potential application value for managing blood - glucose levels.

The study verified the predictive ability of the models by synthesizing 10 peptides and testing their DPP - IV inhibitory properties in vitro. Although there was not a complete agreement between the predicted DPP - IV half - maximal inhibitory concentration (IC50) and the experimentally determined results, two peptides (LPVPQ and IPM) showed strong in vitro DPP - IV inhibitory activity, indicating that these peptides may have the potential to be developed into natural DPP - IV inhibitors for managing blood - glucose levels.